Growth Metrics

Zimmer Biomet Holdings (ZBH) Share-based Compensation (2016 - 2026)

Zimmer Biomet Holdings has reported Share-based Compensation over the past 18 years, most recently at $24.2 million for Q1 2026.

  • For Q1 2026, Share-based Compensation rose 23.47% year-over-year to $24.2 million; the TTM value through Mar 2026 reached $117.0 million, up 27.73%, while the annual FY2025 figure was $90.2 million, 10.69% down from the prior year.
  • Share-based Compensation for Q1 2026 was $24.2 million at Zimmer Biomet Holdings, roughly flat from $24.1 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $43.4 million in Q2 2025 and troughed at $15.6 million in Q3 2023.
  • A 5-year average of $26.0 million and a median of $25.3 million in 2025 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: surged 79.87% in 2022 and later plummeted 43.07% in 2023.
  • Year by year, Share-based Compensation stood at $26.8 million in 2022, then fell by 5.6% to $25.3 million in 2023, then dropped by 16.6% to $21.1 million in 2024, then grew by 14.22% to $24.1 million in 2025, then rose by 0.41% to $24.2 million in 2026.
  • Business Quant data shows Share-based Compensation for ZBH at $24.2 million in Q1 2026, $24.1 million in Q4 2025, and $25.3 million in Q3 2025.